Correlation Between Mineralys Therapeutics, and Dice Molecules

Can any of the company-specific risk be diversified away by investing in both Mineralys Therapeutics, and Dice Molecules at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mineralys Therapeutics, and Dice Molecules into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Mineralys Therapeutics, Common and Dice Molecules Holdings, you can compare the effects of market volatilities on Mineralys Therapeutics, and Dice Molecules and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mineralys Therapeutics, with a short position of Dice Molecules. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mineralys Therapeutics, and Dice Molecules.

Diversification Opportunities for Mineralys Therapeutics, and Dice Molecules

-0.39

Correlation Coefficient

Mineralys Therapeutics,  Dice Molecules

Very good diversification

The 3 months correlation between Mineralys and Dice is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Mineralys Therapeutics, Common and Dice Molecules Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dice Molecules Holdings and Mineralys Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mineralys Therapeutics, Common are associated (or correlated) with Dice Molecules. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dice Molecules Holdings has no effect on the direction of Mineralys Therapeutics, i.e., Mineralys Therapeutics, and Dice Molecules go up and down completely randomly.

Pair Corralation between Mineralys Therapeutics, and Dice Molecules

If you would invest  4,697  in Dice Molecules Holdings on September 28, 2024 and sell it today you would earn a total of  0.00  from holding Dice Molecules Holdings or generate 0.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	4.76%
Values	Daily Returns

Mineralys Therapeutics, Common  vs.  Dice Molecules Holdings

Mineralys Therapeutics,

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Mineralys Therapeutics, Common are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Mineralys Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Dice Molecules Holdings

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Dice Molecules Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental indicators, Dice Molecules is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Mineralys Therapeutics, and Dice Molecules

The main advantage of trading using opposite Mineralys Therapeutics, and Dice Molecules positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mineralys Therapeutics, position performs unexpectedly, Dice Molecules can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dice Molecules will offset losses from the drop in Dice Molecules' long position.

The idea behind Mineralys Therapeutics, Common and Dice Molecules Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.